申请人:Dobler Markus Rolf
公开号:US20120142685A1
公开(公告)日:2012-06-07
The present invention provides a compound formula I: (formula I) said compound is inhibitor of selective subset of kinases belonging to the AGC or calmodulin kinase family, such as for example MARK1/2/3, PKD-1/2/3, PKN-1/2, CDK-9, CaMKII, ROCK-I/II, inhibitors of histone deacetylase (HDAC) phosphorylation, or inhibitors of other kinases. Finally, the present invention also provides a pharmaceutical composition.
本发明提供了一个化合物公式I:(公式I),该化合物是AGC或钙调素激酶家族的选择性亚集的抑制剂,例如MARK1/2/3,PKD-1/2/3,PKN-1/2,CDK-9,CaMKII,ROCK-I/II,组蛋白去乙酰化酶(HDAC)磷酸化抑制剂,或其他激酶的抑制剂。最后,本发明还提供了一种制药组合物。